Eur Radiol: 心房颤动患者左心耳血栓的诊断——延迟对比增强心脏CT

2021-03-15 shaosai MedSci原创

心脏计算机断层扫描(CCT)是一种成熟的评估左心房和肺静脉解剖的影像学技术。CCT影像可结合电生理图引导房颤(AF)导管射频消融。

    心脏计算机断层扫描(CCT)是一种成熟的评估左心房和肺静脉解剖的影像学技术。CCT影像可结合电生理图引导房颤(AF)导管射频消融。此外,CCT作为一种新兴的检测左心耳(LAA)血栓的无创成像方式,已被作为射频导管消融前的常规检查,以降低随后血栓栓塞事件的发生风险。

    虽然CCT是一种敏感性极高的排除心内血栓的影像学方法,但早期成像不能直观地区分循环淤积与LAA或其他心脏部位的血栓,因此特异性和阳性预测价值较低。已有研究表明,当延迟采集时间获取图像时,可以提高CCT诊断LAA血栓的准确性。然而,不同报告的诊断准确性差异很大,很难得出一个明确的结论,这限制了CCT在这种情况下的常规使用。此外,报道的延迟采集时间有很大差异,从30秒到3分钟不等,导致研究结果的特异性和阳性预测值(PPVs)之间存在明显差异。在这种情况下,经食管超声心动图(TEE)被国际指南推荐为诊断LAA血栓的唯一影像学方法,特别是对于持续性房颤患者,但其作为一种半侵入性检查很难在临床上广泛应用。


   近日,发表在European Radiology杂志的一项研究以TEE为参考标准,开发了一种用于诊断房颤(AF)患者LAA血栓的心脏计算机断层扫描(CCT)的最佳方案。

    前瞻性纳入260名因房颤接受射频消融治疗的连续患者。所有患者均在2小时内接受CCT和TEE检查。CCT方案包括一个标准的血管造影扫描和三个延迟扫描,延迟扫描分别在注射造影剂后1分钟、3分钟和6分钟。血栓被定义为延迟6分钟扫描时持续存在的充盈缺损。

    TEE显示自发性强化52例(20%)、血栓10例(4%)。在63例(24%)患者中,CCT显示在血管造影扫描LAA的早期充盈缺损。其中,15人(6%)在1分钟时出现持续的充盈缺损,12人(5%)在3分钟时出现,10人(4%)在6分钟时出现。所有在TEE上诊断的10个血栓都通过延迟CCT正确识别,没有任何假阳性。对所有阶段,敏感性和阴性预测为100%。特异性从血管造影时的79%增加到6分钟时的100%。阳性预测值由16%提高到100%。血管造影扫描的估计辐射暴露为2.08±0.76 mSv(均值±标准差),每个延迟扫描的估计辐射暴露为0.45±0.23 mSv。

表1 延迟对比CCT和经食管超声心动图检测左心耳血栓的一致性。

表2 对比剂注射后在不同时间获得的扫描诊断准确性参数。

图1 不同CCT期相的诊断性能,表示为敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。

图2 一名53岁男子的轴位心脏图像。(a)早期阶段的CCT图像显示了LAA的充盈缺损(黑色箭头),并且在多次进行的后期扫描(b–d)中均存在少量持续性的充盈缺损,提示LAA内有血栓。(e)在CCT确认LAA血栓形成1小时后获得的TEE图像(白色箭头)。

    本研究表明,在CCT扫描方案血管造影扫描后增加6分钟的延迟扫描是诊断LAA血栓的最佳方法,且辐射剂量较低。鉴于LAA血栓的患病率非常低,绝大多数患者的检测结果为阴性,因此CCT延迟扫描方案可作为常规TEE检查的替代性无创检查。


原始出处:

Pietro Spagnolo,Manuela Giglio,Daniela Di Marco,et al. Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT.DOI:10.1007/s00330-020-07172-2

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1998473, encodeId=f94719984e323, content=<a href='/topic/show?id=b71851393ad' target=_blank style='color:#2F92EE;'>#心脏CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51393, encryptionId=b71851393ad, topicName=心脏CT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun Jan 02 09:26:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998327, encodeId=f4c299832e7f, content=好方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Sun Jul 11 00:11:38 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455631, encodeId=35d2145563143, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626949, encodeId=639916269495a, content=<a href='/topic/show?id=986a5101e46' target=_blank style='color:#2F92EE;'>#心房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51017, encryptionId=986a5101e46, topicName=心房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba21064884, createdName=sodoo, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948553, encodeId=c7f494855309, content=每个人都接受CCT和TEE?患者接受度低, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Tue Mar 16 07:39:32 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031362, encodeId=443810313629b, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Tue Mar 16 00:26:21 CST 2021, time=2021-03-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1998473, encodeId=f94719984e323, content=<a href='/topic/show?id=b71851393ad' target=_blank style='color:#2F92EE;'>#心脏CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51393, encryptionId=b71851393ad, topicName=心脏CT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun Jan 02 09:26:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998327, encodeId=f4c299832e7f, content=好方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Sun Jul 11 00:11:38 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455631, encodeId=35d2145563143, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626949, encodeId=639916269495a, content=<a href='/topic/show?id=986a5101e46' target=_blank style='color:#2F92EE;'>#心房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51017, encryptionId=986a5101e46, topicName=心房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba21064884, createdName=sodoo, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948553, encodeId=c7f494855309, content=每个人都接受CCT和TEE?患者接受度低, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Tue Mar 16 07:39:32 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031362, encodeId=443810313629b, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Tue Mar 16 00:26:21 CST 2021, time=2021-03-16, status=1, ipAttribution=)]
    2021-07-11 104843

    好方法

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1998473, encodeId=f94719984e323, content=<a href='/topic/show?id=b71851393ad' target=_blank style='color:#2F92EE;'>#心脏CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51393, encryptionId=b71851393ad, topicName=心脏CT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun Jan 02 09:26:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998327, encodeId=f4c299832e7f, content=好方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Sun Jul 11 00:11:38 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455631, encodeId=35d2145563143, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626949, encodeId=639916269495a, content=<a href='/topic/show?id=986a5101e46' target=_blank style='color:#2F92EE;'>#心房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51017, encryptionId=986a5101e46, topicName=心房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba21064884, createdName=sodoo, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948553, encodeId=c7f494855309, content=每个人都接受CCT和TEE?患者接受度低, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Tue Mar 16 07:39:32 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031362, encodeId=443810313629b, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Tue Mar 16 00:26:21 CST 2021, time=2021-03-16, status=1, ipAttribution=)]
    2021-03-17 jxrzshh
  4. [GetPortalCommentsPageByObjectIdResponse(id=1998473, encodeId=f94719984e323, content=<a href='/topic/show?id=b71851393ad' target=_blank style='color:#2F92EE;'>#心脏CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51393, encryptionId=b71851393ad, topicName=心脏CT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun Jan 02 09:26:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998327, encodeId=f4c299832e7f, content=好方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Sun Jul 11 00:11:38 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455631, encodeId=35d2145563143, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626949, encodeId=639916269495a, content=<a href='/topic/show?id=986a5101e46' target=_blank style='color:#2F92EE;'>#心房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51017, encryptionId=986a5101e46, topicName=心房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba21064884, createdName=sodoo, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948553, encodeId=c7f494855309, content=每个人都接受CCT和TEE?患者接受度低, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Tue Mar 16 07:39:32 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031362, encodeId=443810313629b, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Tue Mar 16 00:26:21 CST 2021, time=2021-03-16, status=1, ipAttribution=)]
    2021-03-17 sodoo
  5. [GetPortalCommentsPageByObjectIdResponse(id=1998473, encodeId=f94719984e323, content=<a href='/topic/show?id=b71851393ad' target=_blank style='color:#2F92EE;'>#心脏CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51393, encryptionId=b71851393ad, topicName=心脏CT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun Jan 02 09:26:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998327, encodeId=f4c299832e7f, content=好方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Sun Jul 11 00:11:38 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455631, encodeId=35d2145563143, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626949, encodeId=639916269495a, content=<a href='/topic/show?id=986a5101e46' target=_blank style='color:#2F92EE;'>#心房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51017, encryptionId=986a5101e46, topicName=心房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba21064884, createdName=sodoo, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948553, encodeId=c7f494855309, content=每个人都接受CCT和TEE?患者接受度低, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Tue Mar 16 07:39:32 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031362, encodeId=443810313629b, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Tue Mar 16 00:26:21 CST 2021, time=2021-03-16, status=1, ipAttribution=)]
    2021-03-16 澄潭映月

    每个人都接受CCT和TEE?患者接受度低

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1998473, encodeId=f94719984e323, content=<a href='/topic/show?id=b71851393ad' target=_blank style='color:#2F92EE;'>#心脏CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51393, encryptionId=b71851393ad, topicName=心脏CT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun Jan 02 09:26:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998327, encodeId=f4c299832e7f, content=好方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Sun Jul 11 00:11:38 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455631, encodeId=35d2145563143, content=<a href='/topic/show?id=d15a4808371' target=_blank style='color:#2F92EE;'>#左心耳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48083, encryptionId=d15a4808371, topicName=左心耳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=386b5684768, createdName=jxrzshh, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626949, encodeId=639916269495a, content=<a href='/topic/show?id=986a5101e46' target=_blank style='color:#2F92EE;'>#心房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51017, encryptionId=986a5101e46, topicName=心房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba21064884, createdName=sodoo, createdTime=Wed Mar 17 12:26:21 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948553, encodeId=c7f494855309, content=每个人都接受CCT和TEE?患者接受度低, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Tue Mar 16 07:39:32 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031362, encodeId=443810313629b, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Tue Mar 16 00:26:21 CST 2021, time=2021-03-16, status=1, ipAttribution=)]
    2021-03-16 心介

    房颤,临床上碰到很多哦

    0

相关资讯

Circulation:基因疗法| 抑制NADPH氧化酶2可预防房颤发生

心房颤动(房颤,AF)是成年人最常见的心律紊乱,也是卒中的主要原因。不幸的是,目前对AF的治疗因为没有针对房颤潜在的分子机制而是次优的。在犬房颤快速心房起搏模型中使用一种非常新颖的基因治疗方法,Yoo

Am Heart J:钾的输注增加了近期发作的房颤转变为窦性心律的可能性

近期发作的房颤(ROAF)或房扑的最佳抗心律失常管理存在争议,临床治疗策略也存在相当大的差异。目前尚不清楚输钾是否有可能将ROAF或房扑转化为窦性心律(SR)。因此,本研究旨在探究ROAF或心房扑动且

JAHA:这一人群卒中风险与房颤无关!

JAHA:无论是否罹患房颤,美国印第安那人群发生缺血性卒中的风险最高!

Stroke:房颤患者中,较高的BMI或降低脑血管事件风险

房颤患者中,较高的BMI或降低脑血管事件风险

GW-ICC 2020:苏晞:冷冻消融并发症的真实数据和管理

肺静脉隔离(PVI)是心房颤动导管消融的基石,应用冷冻球囊导管进行肺静脉隔离的有效性和安全性获得了临床研究证实,国内外指南已将冷冻球囊消融(CBA)作为房颤消融的标准疗法。